港股通创新药ETF工银获融资买入0.12亿元，近三日累计买入0.67亿元

Core Viewpoint - The recent trading data indicates a steady interest in the Hong Kong Stock Connect Innovative Drug ETF, with notable financing activities over the past few days [1] Group 1: Financing Activities - On August 12, the Hong Kong Stock Connect Innovative Drug ETF received a financing buy amount of 0.12 billion, ranking 2221 among the two markets [1] - The financing repayment amount on the same day was 0.10 billion, resulting in a net buy of 2.37 million [1] - Over the last three trading days (August 8-12), the ETF received financing buy amounts of 0.35 billion, 0.20 billion, and 0.12 billion respectively [1] Group 2: Short Selling Activities - On August 12, there were no shares sold short, with a net short sale of 0.00 shares [1]